Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,650Revenue (TTM) $M--Net Margin (%)--Altman Z-Score
Enterprise Value $M-30.2EPS (TTM) $--Operating Margin %--Piotroski F-Score--
P/E(ttm)23.8Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book3.610-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %1.8PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M16,250,000ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with IXJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
IXJKen Fisher 2016-06-30 Add$96.03 - $102.9
($99.72)
$ 101.552%Add 45.39%17,624
IXJKen Fisher 2016-03-31 Reduce-0.02%$90.5 - $102.62
($95.44)
$ 101.556%Reduce -86.86%12,122
IXJKen Fisher 2015-12-31 Add0.02%$99.78 - $105.97
($102.96)
$ 101.55-1%Add 380.03%92,228
IXJKen Fisher 2015-09-30 Add$96.45 - $113.73
($107.78)
$ 101.55-6%Add 187.71%19,213
IXJKen Fisher 2015-06-30 Add$107.16 - $112.88
($109.98)
$ 101.55-8%Add 9.14%6,678
IXJKen Fisher 2015-03-31 Reduce$98.86 - $110.66
($104.83)
$ 101.55-3%Reduce -13.27%6,119
IXJKen Fisher 2014-03-31 Buy $84.91 - $93
($89.14)
$ 101.5514%New holding5,950
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

IXJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


IXJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Element, MartynDirector 2016-08-08Buy10,000$0.1567600view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell200$12.1739.26view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell1,800$12.1739.26view
Finch, S. WayneDirector, Senior Officer 2016-08-08Sell2,000$12.11738.56view
Ghuldu, RishiSenior Officer 2016-08-08Sell149$23.45333.05view
Louis, PeterSenior Officer 2016-08-08Sell5,000$87.8615.58view
Omni-Lite Industries Canada InIssuer 2016-08-08Buy5,000$1.75873.53view
Omni-Lite Industries Canada InIssuer 2016-08-08Buy4,700$1.656054.55view
Kovacevic, John GianniDirector, Senior Officer 2016-08-08Buy200,000$0.08126837.5view
Espaillat Lamarche, Julio ErneSenior Officer 2016-08-08Sell190,000$0.616825view

Quarterly/Annual Reports about IXJ:

    News about IXJ:

    Articles On GuruFocus.com
    No related article found.

    More From Other Websites
    AstraZeneca’s Recent Product Developments Aug 25 2016
    AstraZeneca and Its Oncology Segment’s Growth in 2Q16 Aug 25 2016
    How Crestor Weakened AstraZeneca’s CVMD Segment in 2Q16 Aug 24 2016
    Remicade Is Driving Down Merck’s Immunology Franchise Aug 16 2016
    How Are Eli Lilly’s New Products Performing? Aug 04 2016
    Revenues from Eli Lilly’s Cymbalta Are Depressed Internationally Aug 03 2016
    What to Expect from Pfizer’s 2Q16 Earnings Aug 01 2016
    How Did JNJ’s Pharmaceutical Segment Fare in 2Q16? Jul 22 2016
    Understanding Lilly’s New Product Expectations for 2Q16 Jul 22 2016
    Inside Lilly’s 2Q16 Estimates for Its Neuroscience Franchise Jul 22 2016
    Why AbbVie Continues to Explore Imbruvica for Diffuse Large B-Cell Lymphoma Jul 06 2016
    AstraZeneca’s Key Focus: Oncology Jun 06 2016
    What’s AstraZeneca’s Largest Revenue Contributor? Jun 01 2016
    Government Study: Cellphone Radiation Linked To Cancer May 27 2016
    Recovery for the Manufacturing Sector Is Not Yet in Sight May 18 2016
    Why Is Remicade Driving Down Merck’s Performance? May 16 2016
    How Is Gardasil Driving Merck’s Vaccines Business? May 13 2016
    Thematic ETFs: Smarter Than Regular Smart Beta ETFs? May 13 2016

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)